Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Disc Medicine Inc

< Previous 1 2 Next >
Disc Medicine Receives FDA Fast Track Designation for DISC-0974 for the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
Disc Medicine Receives FDA Orphan Drug Designation for DISC-3405 for the Treatment of Polycythemia Vera
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
Disc Medicine Strengthens Leadership Team with Appointment of Seasoned Industry Executive Jean Franchi as Chief Financial Officer, and Promotion of Jonathan Yu to Chief Operating Officer
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
Disc Medicine to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
Disc Medicine Announces Retirement of Brian MacDonald, MB, ChB, PhD as Chief Innovation Officer and Appointment as Chair of Scientific Advisory Board
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
Disc Presents Positive Updated Results from Phase 2 BEACON Study of Bitopertin and Other Programs at the 65th American Society of Hematology (ASH) Annual Meeting
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
Disc Presents Initial Positive Data from Ongoing Phase 1b/2 Trial of DISC-0974 in Patients with Myelofibrosis (MF) and Anemia at the 65th American Society of Hematology (ASH) Annual Meeting
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
Disc Medicine Announces Grant of US Patent for Methods of Treating Erythropoietic Protoporphyrias with Bitopertin
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
Disc Medicine Reports Third Quarter 2023 Financial Results and Provides Business Update
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
Disc Medicine to Participate in Upcoming Investor Conferences
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
Disc Medicine Announces Multiple Presentations Across Portfolio at the 65th American Society of Hematology Annual Meeting and Key Program Updates
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
Disc Medicine Announces Planned Departure of Chief Financial Officer Joanne Bryce
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
Disc Medicine Initiates a Phase 1 Study of DISC-3405 (anti-TMPRSS6 mAb) in Healthy Volunteers
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
Disc Medicine Receives FDA Fast Track Designation for MWTX-003 for the Treatment of Polycythemia Vera
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
Disc Medicine to Participate in Upcoming Investor Conferences
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
Disc Medicine Reports Second Quarter 2023 Financial Results and Provides Business Update
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
Disc Medicine Announces First Patient Enrolled in Phase 1/2 Clinical Trial of Bitopertin in Diamond-Blackfan Anemia (DBA)
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
Disc Medicine Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
Disc Medicine Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
Disc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
Disc Presents Positive Initial Data from Phase 2 BEACON Trial of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP) at European Hematology Association (EHA) 2023 Congress
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
Disc Medicine to Participate in the Jefferies Healthcare Conference
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
Disc Medicine Reports First Quarter 2023 Financial Results and Provides Business Update
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
Disc Medicine Announces Presentation of Initial Data from Phase 2 BEACON Trial in Patients with Erythropoietic Protoporphyria (EPP) at European Hematology Association (EHA) 2023 Congress
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
Disc Medicine to Participate in H.C. Wainwright BioConnect Investor Conference
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
Disc Medicine to Host Disease Webinar with KOLs on Erythropoietic Protoporphyria (EPP)
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
Disc Medicine Reports Full Year 2022 Financial Results and Provides Business Update
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
Disc Medicine Announces Collaboration with National Institutes of Health for Phase 2 Clinical Study of Bitopertin in Patients with Diamond-Blackfan Anemia (DBA)
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
Disc Medicine Initiates a Phase 1b/2 Clinical Study of DISC-0974 in Adults with Non-Dialysis Dependent Chronic Kidney Disease (NDD-CKD) and Anemia
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
Disc Medicine Announces $62.5 Million Financing led by Bain Capital Life Sciences to Advance Portfolio of Novel Hematology Programs
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.